Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Y-mAbs Therapeutics Inc
Non-Reccuring Items
Y-mAbs Therapeutics Inc
Non-Reccuring Items Peer Comparison
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
Non-Reccuring Items
-$4.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Non-Reccuring Items
-$3.8B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Non-Reccuring Items
-$7.1B
|
CAGR 3-Years
-764%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Non-Reccuring Items
$10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Non-Reccuring Items
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Non-Reccuring Items
-$137.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Y-mAbs Therapeutics Inc's Non-Reccuring Items?
Non-Reccuring Items
-4.5m
USD
Based on the financial report for Dec 31, 2023, Y-mAbs Therapeutics Inc's Non-Reccuring Items amounts to -4.5m USD.